The CASP8AP2 Knockout HEK293T Polyclonal Cells provide a ready-to-use CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the CASP8AP2 gene in a human embryonic kidney background. This heterogeneous pool, generated by transient Cas9 and guide RNA delivery, avoids the limitations of clonal selection and enables immediate functional studies. The polyclonal format captures a spectrum of loss-of-function alleles, offering a robust model for apoptosis and NF-??B pathway interrogation without clonal artifacts. Researchers can directly apply these cells to death receptor signaling assays, leveraging the knockout population to dissect CASP8AP2-dependent molecular mechanisms.
HEK293T is a widely utilized human embryonic kidney cell line transformed with adenovirus 5 DNA and stably expressing the SV40 large T antigen, which drives high-level episomal replication of plasmids containing the SV40 origin. This immortalized epithelial line exhibits exceptional transfection efficiency, rapid growth, and reliable protein expression, making it a workhorse for recombinant protein production, lentivirus packaging, and functional genomics. The epigenetic and signaling competence of HEK293T cells renders them particularly suitable for ectopic pathway analysis, as they retain core apoptotic machinery and NF-??B signaling modules. The combination of this tractable host with targeted CASP8AP2 disruption creates a versatile platform for mechanistic cell biology.
CASP8AP2, also known as FLASH (FLICE-associated huge protein), encodes a large scaffold protein that coordinates death receptor-mediated signaling. It directly interacts with caspase-8 and FADD at the death-inducing signaling complex, facilitating caspase-8 dimerization and activation upon stimulation by TNF, TRAIL, or FasL. In parallel, CASP8AP2 engages DR3 and TRAF2 to modulate NF-??B transcriptional responses, acting as a molecular switch between apoptosis and survival. The protein thus integrates upstream death ligands into bifurcated downstream cascades: caspase-8?Cdriven proteolytic apoptosis or IKK complex?Cdependent NF-??B activation, which regulates genes involved in inflammation, proliferation, and drug resistance.
In the HEK293T context, ablation of CASP8AP2 permits selective interrogation of these competing pathways without interference from tissue-specific modulators. Because HEK293T cells express key death receptors and downstream effectors, the knockout allows clear attribution of functional outcomes to CASP8AP2. For instance, reduced caspase-8 processing and attenuated apoptosis in response to TRAIL can be specifically linked to loss of scaffold function, while altered NF-??B reporter activity reveals the protein??s role in signal bifurcation. The high transfection efficiency further enables complementation studies with mutant FLASH constructs to map interaction domains with FADD, caspase-8, or TRAF2, making these cells a powerful tool for structure-function analyses in a simplified cellular environment.
These polyclonal knockout cells are ideal for a range of apoptosis and immune signaling applications, including quantitative flow cytometry?Cbased Annexin V assays, caspase-8 activity measurements, and NF-??B luciferase reporter experiments. They support co-immunoprecipitation of death receptor complexes to examine assembly in the absence of CASP8AP2, as well as cell viability profiling under titrated TNF or TRAIL treatment to assess chemoresistance mechanisms. Western blotting can validate downstream signaling changes, and the pooled knockout format provides a realistic model for heterogeneity in cancer or autoimmune disease research. Typical experimental workflows incorporate these cells to validate gene function, screen for pathway modulators, or explore drug sensitivity. For further technical information or customization options, please contact Ascent Research.
